StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BMRA

Biomerica, Inc.

BMRA Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗
$1.53
-0.06 -3.77%

Key statistics

from XBRL data in SEC filings
Market cap
$4.73M
Revenue (TTM)
$4.33M
Net income (TTM)
-$4.17M
EPS (TTM)
$-1.88
P/E ratio
Dividend yield
Free cash flow
-$3.89M
Cash
$1.34M
Total assets
$4.88M
Gross margin
4.3%
52-week range
$1.45 – $4.60

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Took on a direct financial obligation Jun 4, 2026 10-Q Quarter ended 2026-02-28 Apr 13, 2026 10-Q Quarter ended 2025-11-30 Jan 14, 2026 8-K Shareholder vote results Dec 16, 2025 10-Q Quarter ended 2025-08-31 Oct 14, 2025 8-K Director or officer change; Regulation FD disclosure Oct 8, 2025 10-K/A Fiscal year ended 2025-05-31 Sep 26, 2025 10-K Fiscal year ended 2025-05-31 Aug 29, 2025 8-K Director or officer change; Regulation FD disclosure Jun 6, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Apr 16, 2025 10-Q Quarter ended 2025-02-28 Apr 14, 2025 10-Q Quarter ended 2024-11-30 Jan 14, 2025 8-K Shareholder vote results Dec 17, 2024 8-K Delisting notice or listing-rule failure Nov 6, 2024 10-Q Quarter ended 2024-08-31 Oct 15, 2024 10-K Fiscal year ended 2024-05-31 Aug 28, 2024 8-K Director or officer change Jun 28, 2024 8-K Entered a material agreement; Delisting notice or listing-rule failure May 10, 2024 10-Q Quarter ended 2024-02-29 Apr 12, 2024 10-Q Quarter ended 2023-11-30 Jan 16, 2024 8-K Shareholder vote results Dec 11, 2023 10-Q Quarter ended 2023-08-31 Oct 12, 2023 8-K Regulation FD disclosure Sep 19, 2023 8-K Director or officer change Aug 28, 2023 10-K Fiscal year ended 2023-05-31 Aug 25, 2023 8-K Amended charter or bylaws Jul 26, 2023 8-K Regulation FD disclosure Apr 25, 2023 10-Q Quarter ended 2023-02-28 Apr 14, 2023 8-K Entered a material agreement; Regulation FD disclosure Mar 7, 2023 8-K Director or officer change Mar 2, 2023 8-K Regulation FD disclosure Feb 7, 2023 10-Q Quarter ended 2022-11-30 Jan 13, 2023 8-K/A Shareholder vote results Dec 29, 2022 8-K Director or officer change Dec 16, 2022 8-K Director or officer change Dec 16, 2022 8-K Shareholder vote results Dec 9, 2022 8-K Director or officer change Dec 9, 2022 8-K Regulation FD disclosure Nov 14, 2022 10-Q Quarter ended 2022-08-31 Oct 13, 2022 10-K Fiscal year ended 2022-05-31 Aug 29, 2022